Using the C. elegans Oocyte to Model the Cell Biology of Early Onset Dystonia
Using the C. elegans Oocyte to Model the Cell Biology of Early Onset Dystonia
批准号:
9021284
负责人:
David Irwin Greenstein
金额:
$22.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-15 至 2017-07-31
关键词:
AddressAgeAnimalsBiochemicalBiologicalCaenorhabditis elegansCell NucleusCell physiologyCellsCellular biologyChildDefectDevelopmentDystoniaEarly Onset DystoniaEmbryoEmbryonic DevelopmentEssential TremorExperimental ModelsGenesGeneticGenetic ModelsGenetic ScreeningGlutamic AcidGoalsGrowthHomologous GeneHumanImageInheritedLifeLimb structureMediatingMeiosisMessenger RNAModelingMolecularMolecular GeneticsMovement DisordersMuscle ContractionMutationNematodaNeurologicNeuronsNuclear EnvelopeNuclear ExportOocytesOogenesisParkinson DiseasePathogenesisPathway interactionsPositioning AttributePosturePrevalenceProcessProtein BiosynthesisProteinsRecovery of FunctionResearchResolutionRibonucleoproteinsRoleSiteSuppressor MutationsSymptomsSynapsesSystemTestingTorsinATranslatingTranslational RegulationWalkingWorkbasecellular imagingearly onsetexperiencefunctional restorationgenetic manipulationhigh rewardhigh riskinsightmRNA Exportmutantneuromuscular functionnovelparticleprotein complexprotein functionrestorationtemporal measurementtooltrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Early onset dystonia or DYT1 dystonia is a debilitating neurological movement disorder that first presents in
children at a mean age of about 12. DYT1 dystonia is caused by a mutation in the DYT1/Tor1a gene that
encodes the evolutionarily conserved torsinA protein resulting in the deletion of a single glutamic acid residue
(ΔE302/303 or ΔE). The mechanism through which the ΔE mutation causes DYT1 dystonia is unclear because
the basic cellular function of torsinA is unknown. Intriguing new work suggests that torsinA might function in a
new cellular mechanism by which large ribonucleoprotein particles (RNPs) are exported from the nucleus via
budding through the nuclear envelope. When this function of torsinA is perturbed, messenger RNAs appear to
inefficiently traffic to their synaptic sites of protein synthesis, compromising neuromuscular function. The field
needs to know whether this new model is correct, and if so, to identify the specific molecular mechanisms by
which torsinA promotes nuclear envelope budding for RNP export.
This application seeks to address these goals using the oocytes of the nematode Caenorhabditis
elegans as a tractable experimental model. Mutations in the best characterized C. elegans torsinA homolog
(called ooc-5 for oocyte formation abnormal five) cause defects in oocyte growth. The oocyte growth defect is
the earliest developmental abnormality observed in ooc-5 mutants and therefore is likely reflective of the
primary underlying biochemical and cell biological deficits observed in cells lacking torsinA/OOC-5 function.
Our hypothesis is that ooc-5 mutations disrupt oogenesis by interfering in part with the nuclear export
assembly, or function of oocyte growth-promoting RNPs that we have defined. Given its extensive evolutionary
conservation, OOC-5/torsinA is likely to perform the same elemental protein function in C. elegans oocytes and
mammalian neurons. Interestingly, prior work has shown that the mechanisms of translational regulation
discovered in C. elegans oocytes are also important for the development and function mammalian neurons.
This proposal capitalizes on the many experimental advantages afforded by the C. elegans germline system,
including the ability to conduct high-resolution live-cell imaging and the ease of molecular genetic and
biochemical manipulations. Further, our group has spent two decades pioneering the mechanisms controlling
oocyte development in C. elegans. Recently, we defined proteins and mRNA components of RNPs that
regulate the growth, meiotic development, and developmental potential of C. elegans oocytes. Our research
team is thus ideally positioned to critically test the generality of an RNP budding role for torsinA. To assess this
new role for torsinA, we will: (1) Analyze the cellular mechanisms by which OOC-5 controls the oocyte growth
process; and (2) Define genetic networks that can restore function to ooc-5/torsinA mutants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The C. elegans Germline: A Test Tube for Cell and Developmental Biology
-
批准号:10893272
-
项目类别:
-
资助金额:$6.22万
-
财政年份:2022
-
负责人:David Irwin Greenstein
-
依托单位:
The C. elegans Germline: A Test Tube for Cell and Developmental Biology
-
批准号:10794670
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2022
-
负责人:David Irwin Greenstein
-
依托单位:
The C. elegans Germline: A Test Tube for Cell and Developmental Biology
-
批准号:10328427
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2022
-
负责人:David Irwin Greenstein
-
依托单位:
The C. elegans Germline: A Test Tube for Cell and Developmental Biology
-
批准号:10578828
-
项目类别:
-
资助金额:$44.95万
-
财政年份:2022
-
负责人:David Irwin Greenstein
-
依托单位:
Training Research Educators in Minnesota (TREM) whilst increasing diversity
-
批准号:9895826
-
项目类别:
-
资助金额:$77.77万
-
财政年份:2017
-
负责人:David Irwin Greenstein
-
依托单位:
The Minnesota IRACDA Program
-
批准号:10682507
-
项目类别:
-
资助金额:$66.45万
-
财政年份:2017
-
负责人:David Irwin Greenstein
-
依托单位:
A COPAS BIOSORT Flow Cytometer for Caenorhabditis elegans Molecular Genetics
-
批准号:8048454
-
项目类别:
-
资助金额:$40.92万
-
财政年份:2011
-
负责人:David Irwin Greenstein
-
依托单位:
ANALYSIS OF THE STE13 COMPLEX IN S. POMBE
-
批准号:6979678
-
项目类别:
-
资助金额:$0.36万
-
财政年份:2004
-
负责人:David Irwin Greenstein
-
依托单位:
Control of Oocyte Maturation in C. elegans
-
批准号:6709321
-
项目类别:
-
资助金额:$28.54万
-
财政年份:2002
-
负责人:David Irwin Greenstein
-
依托单位:
Control of Oocyte Maturation in C. elegans
-
批准号:6622790
-
项目类别:
-
资助金额:$28.54万
-
财政年份:2002
-
负责人:David Irwin Greenstein
-
依托单位:
Control of Oocyte Maturation in C. elegans
-
批准号:7337111
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2002
-
负责人:David Irwin Greenstein
-
依托单位:
Control of Oocyte Maturation in C. elegans
-
批准号:8209079
-
项目类别:
-
资助金额:$33.58万
-
财政年份:2002
-
负责人:David Irwin Greenstein
-
依托单位:
Control of Oocyte Maturation in C. elegans
-
批准号:8401909
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2002
-
负责人:David Irwin Greenstein
-
依托单位:
Control of Oocyte Maturation in C. elegans
-
批准号:7192739
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2002
-
负责人:David Irwin Greenstein
-
依托单位:
Control of Oocyte Maturation in C. elegans
-
批准号:8600284
-
项目类别:
-
资助金额:$33.56万
-
财政年份:2002
-
负责人:David Irwin Greenstein
-
依托单位:
Control of Oocyte Maturation in C. elegans
-
批准号:7541729
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2002
-
负责人:David Irwin Greenstein
-
依托单位:
Control of Oocyte Maturation in C. elegans
-
批准号:6455672
-
项目类别:
-
资助金额:$28.56万
-
财政年份:2002
-
负责人:David Irwin Greenstein
-
依托单位:
Control of Oocyte Maturation in C. elegans
-
批准号:6855780
-
项目类别:
-
资助金额:$28.54万
-
财政年份:2002
-
负责人:David Irwin Greenstein
-
依托单位:
Control of Oocyte Maturation in C. elegans
-
批准号:7996371
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2002
-
负责人:David Irwin Greenstein
-
依托单位:
CONTROL OF MEIOSIS AND GERMLINE PROLIFERATION
-
批准号:6386828
-
项目类别:
-
资助金额:$18.91万
-
财政年份:1998
-
负责人:David Irwin Greenstein
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: